AirFluSal’s Decentralized Approach to EU Shields Seretide From Exposure
This article was originally published in The Pink Sheet Daily
Executive Summary
Sandoz’ AirFluSal Forspiro has been approved in Germany, but the company’s decentralized route into Europe means that GSK’s Seretide is somewhat shielded from all-out competition.